Regeneron Pharmaceuticals Inc. partners with Fujifilm Diosynth Biotechnologies in a $3 billion deal to enhance US production of biologic medicines, with total investments in produc...
Regeneron Pharmaceuticals Inc. has signed a $3 billion deal with Fujifilm Diosynth Biotechnologies to produce biologic medicines in North Carolina, marking a significant investment...
Regeneron Pharmaceuticals Inc. and Fujifilm Diosynth Biotechnologies have signed a $3 billion deal to produce biologic medicines in North Carolina, marking a significant investment...
Regeneron Pharmaceuticals Inc. and Fujifilm Diosynth Biotechnologies have announced a $3 billion partnership to enhance the production of biologic medicines in the US, with additio...
Regeneron Pharmaceuticals Inc. and Fujifilm Diosynth Biotechnologies have announced a $3 billion deal to produce biologic medicines in North Carolina, marking a significant step in...
